1,2-dichloroethane increases expression ISO RGD:735968 6480464 ethylene dichloride results in increased expression of MAPK12 mRNA CTD PMID:28960355 1-chloro-2,4-dinitrobenzene decreases methylation ISO RGD:735968 6480464 Dinitrochlorobenzene results in decreased methylation of MAPK12 promoter CTD PMID:24675093 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAPK12 mRNA CTD PMID:33387578 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MAPK12 mRNA CTD PMID:24780913 acetylsalicylic acid decreases expression ISO RGD:731716 6480464 Aspirin results in decreased expression of MAPK12 mRNA CTD PMID:20514442 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of MAPK12 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:731716 6480464 Acrylamide results in decreased expression of MAPK12 mRNA CTD PMID:32763439 afimoxifene decreases response to substance ISO RGD:731716 6480464 MAPK12 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 decreases methylation ISO RGD:731716 6480464 Aflatoxin B1 results in decreased methylation of MAPK12 intron CTD PMID:30157460 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAPK12 mRNA CTD PMID:16483693 amsacrine multiple interactions ISO RGD:731716 6480464 [MAPK12 protein results in increased phosphorylation of TOP2A protein] which results in increased susceptibility to Amsacrine, [MAPK12 protein results in increased stability of TOP2A protein] which results in increased susceptibility to Amsacrine CTD PMID:21878638 amsacrine affects response to substance ISO RGD:731716 6480464 MAPK12 protein affects the susceptibility to Amsacrine CTD PMID:21878638 amsacrine increases activity ISO RGD:731716 6480464 Amsacrine results in increased activity of MAPK12 protein CTD PMID:21878638 arsenite(3-) multiple interactions ISO RGD:735968 6480464 MAPK12 protein affects the reaction [[sodium arsenite results in increased abundance of arsenite] which results in increased expression of PTGS2 protein] CTD PMID:23639288 benzo[a]pyrene decreases expression ISO RGD:735968 6480464 Benzo(a)pyrene results in decreased expression of MAPK12 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:731716 6480464 Benzo(a)pyrene affects the methylation of MAPK12 promoter CTD PMID:27901495 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAPK12 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:735968 6480464 bisphenol A results in increased expression of MAPK12 mRNA CTD PMID:32156529 bisphenol A affects expression ISO RGD:731716 6480464 bisphenol A affects the expression of MAPK12 mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:731716 6480464 bisphenol A results in increased expression of MAPK12 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MAPK12 gene CTD PMID:28505145 cadmium dichloride decreases expression ISO RGD:731716 6480464 Cadmium Chloride results in decreased expression of MAPK12 protein CTD PMID:19757093 cadmium dichloride increases expression ISO RGD:731716 6480464 Cadmium Chloride results in increased expression of MAPK12 mRNA CTD PMID:19757093 cadmium dichloride multiple interactions ISO RGD:735968 6480464 MAPK12 mutant form inhibits the reaction [MAP2K4 mutant form inhibits the reaction [Cadmium Chloride results in increased expression of HSPA1A protein]], MAPK12 mutant form promotes the reaction [Cadmium Chloride results in increased expression of HSPA1A protein] CTD PMID:18348256 calciol increases expression ISO RGD:735968 6480464 Cholecalciferol results in increased expression of MAPK12 mRNA CTD PMID:17170073 cannabidiol decreases expression ISO RGD:731716 6480464 Cannabidiol results in decreased expression of MAPK12 mRNA CTD PMID:27714895 more ... carbon nanotube decreases expression ISO RGD:735968 6480464 Nanotubes, Carbon results in decreased expression of MAPK12 mRNA CTD PMID:25554681 cisplatin increases expression ISO RGD:731716 6480464 Cisplatin results in increased expression of MAPK12 mRNA CTD PMID:21603599 cisplatin multiple interactions ISO RGD:731716 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of MAPK12 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:731716 6480464 cobaltous chloride results in decreased expression of MAPK12 mRNA CTD PMID:19320972 , PMID:26314263 copper atom multiple interactions ISO RGD:731716 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAPK12 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of MAPK12 mRNA CTD PMID:20971185 , PMID:30911355 copper(0) multiple interactions ISO RGD:731716 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAPK12 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of MAPK12 mRNA CTD PMID:20971185 , PMID:30911355 crocidolite asbestos decreases expression ISO RGD:735968 6480464 Asbestos, Crocidolite results in decreased expression of MAPK12 mRNA CTD PMID:29279043 curcumin increases activity ISO RGD:731716 6480464 Curcumin results in increased activity of MAPK12 protein CTD PMID:21594647 cyclosporin A decreases expression ISO RGD:731716 6480464 Cyclosporine results in decreased expression of MAPK12 mRNA CTD PMID:27989131 D-glucitol increases phosphorylation ISO RGD:731716 6480464 Sorbitol results in increased phosphorylation of MAPK12 protein CTD PMID:15362974 deguelin decreases expression ISO RGD:731716 6480464 deguelin results in decreased expression of MAPK12 mRNA CTD PMID:33512557 deoxynivalenol decreases expression ISO RGD:731716 6480464 deoxynivalenol results in decreased expression of MAPK12 mRNA CTD PMID:31863870 diazinon affects expression EXP 6480464 Diazinon affects the expression of MAPK12 mRNA CTD PMID:22546817 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of MAPK12 mRNA CTD PMID:22546817 disodium selenite decreases expression ISO RGD:731716 6480464 Sodium Selenite results in decreased expression of MAPK12 mRNA CTD PMID:16705456 dorsomorphin multiple interactions ISO RGD:731716 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:731716 6480464 [TP53 protein affects the susceptibility to Doxorubicin] which affects the expression of MAPK12 mRNA CTD PMID:36634904 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAPK12 mRNA CTD PMID:29391264 ethanol increases expression EXP 6480464 Ethanol results in increased expression of MAPK12 mRNA CTD PMID:17920746 etoposide increases activity ISO RGD:731716 6480464 Etoposide results in increased activity of MAPK12 protein CTD PMID:21878638 etoposide affects response to substance ISO RGD:731716 6480464 MAPK12 protein affects the susceptibility to Etoposide CTD PMID:21878638 etoposide multiple interactions ISO RGD:731716 6480464 [MAPK12 protein results in increased phosphorylation of TOP2A protein] which results in increased susceptibility to Etoposide, [MAPK12 protein results in increased stability of TOP2A protein] which results in increased susceptibility to Etoposide CTD PMID:21878638 lapatinib multiple interactions ISO RGD:731716 6480464 lapatinib inhibits the reaction [EGFR protein binds to MAPK12 protein] more ... CTD PMID:28739874 methoxyacetic acid affects expression EXP 6480464 methoxyacetic acid affects the expression of MAPK12 mRNA CTD PMID:20864626 methyl methanesulfonate decreases expression ISO RGD:731716 6480464 Methyl Methanesulfonate results in decreased expression of MAPK12 mRNA CTD PMID:23649840 methylmercury(1+) decreases expression ISO RGD:731716 6480464 methylmercury II results in decreased expression of MAPK12 mRNA CTD PMID:26314263 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of MAPK12 mRNA CTD PMID:28954212 myristicin decreases expression ISO RGD:731716 6480464 myristicin results in decreased expression of MAPK12 mRNA CTD PMID:24792648 N-methyl-4-phenylpyridinium decreases expression ISO RGD:731716 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAPK12 mRNA CTD PMID:25234470 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MAPK12 mRNA CTD PMID:22546817 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:731716 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MAPK12 gene CTD PMID:30521419 obeticholic acid decreases expression ISO RGD:731716 6480464 obeticholic acid results in decreased expression of MAPK12 mRNA CTD PMID:27939613 ochratoxin A decreases expression ISO RGD:731716 6480464 ochratoxin A metabolite results in decreased expression of MAPK12 mRNA, ochratoxin A results in decreased expression of MAPK12 mRNA CTD PMID:26314263 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of MAPK12 mRNA CTD PMID:23665939 perfluorooctane-1-sulfonic acid increases expression ISO RGD:735968 6480464 perfluorooctane sulfonic acid results in increased expression of MAPK12 mRNA CTD PMID:26300304 pirfenidone multiple interactions ISO RGD:731716 6480464 [pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]] which results in decreased phosphorylation of PTPN3 protein more ... CTD PMID:22399296 , PMID:28739874 pirinixic acid multiple interactions ISO RGD:735968 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAPK12 mRNA CTD PMID:19710929 SB 203580 decreases expression ISO RGD:731716 6480464 SB 203580 results in decreased expression of MAPK12 mRNA CTD PMID:19757093 SB 431542 multiple interactions ISO RGD:731716 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite multiple interactions ISO RGD:735968 6480464 MAPK12 protein affects the reaction [[sodium arsenite results in increased abundance of arsenite] which results in increased expression of PTGS2 protein] CTD PMID:23639288 sodium arsenite multiple interactions ISO RGD:731716 6480464 sodium arsenite results in increased phosphorylation of and results in increased activity of MAPK12 protein CTD PMID:15504454 tamoxifen multiple interactions ISO RGD:731716 6480464 [pirfenidone inhibits the reaction [MAPK12 protein results in increased expression of JUN protein]] which results in decreased susceptibility to Tamoxifen more ... CTD PMID:22399296 tamoxifen increases phosphorylation ISO RGD:731716 6480464 Tamoxifen results in increased phosphorylation of MAPK12 protein CTD PMID:22399296 tamoxifen decreases response to substance ISO RGD:731716 6480464 MAPK12 mutant form results in decreased susceptibility to Tamoxifen CTD PMID:22399296 tert-butyl hydroperoxide increases expression ISO RGD:735968 6480464 tert-Butylhydroperoxide results in increased expression of MAPK12 mRNA CTD PMID:14729362 tetrachloromethane increases expression ISO RGD:731716 6480464 Carbon Tetrachloride results in increased expression of MAPK12 mRNA CTD PMID:11566570 tetrachloromethane affects expression ISO RGD:735968 6480464 Carbon Tetrachloride affects the expression of MAPK12 mRNA CTD PMID:17484886 tipifarnib increases expression EXP 6480464 tipifarnib results in increased expression of MAPK12 mRNA CTD PMID:16403772 tributylstannane decreases expression ISO RGD:731716 6480464 tributyltin results in decreased expression of MAPK12 mRNA CTD PMID:26314263 Tributyltin oxide decreases expression ISO RGD:731716 6480464 bis(tri-n-butyltin)oxide results in decreased expression of MAPK12 mRNA CTD PMID:26314263 trichostatin A decreases expression ISO RGD:731716 6480464 trichostatin A results in decreased expression of MAPK12 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:731716 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAPK12 mRNA CTD PMID:27188386 valproic acid increases methylation ISO RGD:731716 6480464 Valproic Acid results in increased methylation of MAPK12 gene CTD PMID:29154799 vorinostat decreases expression ISO RGD:731716 6480464 vorinostat results in decreased expression of MAPK12 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:731716 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAPK12 mRNA CTD PMID:27188386 xanthohumol decreases phosphorylation ISO RGD:731716 6480464 xanthohumol results in decreased phosphorylation of MAPK12 protein CTD PMID:35229981 zinc atom increases expression ISO RGD:731716 6480464 Zinc deficiency results in increased expression of MAPK12 mRNA CTD PMID:12888634 zinc(0) increases expression ISO RGD:731716 6480464 Zinc deficiency results in increased expression of MAPK12 mRNA CTD PMID:12888634